These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31907057)
41. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen. Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084 [TBL] [Abstract][Full Text] [Related]
42. Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1. Braden BC; Souchon H; Eiselé JL; Bentley GA; Bhat TN; Navaza J; Poljak RJ J Mol Biol; 1994 Nov; 243(4):767-81. PubMed ID: 7966295 [TBL] [Abstract][Full Text] [Related]
43. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24. Monaco-Malbet S; Berthet-Colominas C; Novelli A; Battaï N; Piga N; Cheynet V; Mallet F; Cusack S Structure; 2000 Oct; 8(10):1069-77. PubMed ID: 11080628 [TBL] [Abstract][Full Text] [Related]
44. Structure, function and properties of antibody binding sites. Mian IS; Bradwell AR; Olson AJ J Mol Biol; 1991 Jan; 217(1):133-51. PubMed ID: 1988675 [TBL] [Abstract][Full Text] [Related]
45. Different binding modes of free and carrier-protein-coupled nicotine in a human monoclonal antibody. Tars K; Kotelovica S; Lipowsky G; Bauer M; Beerli RR; Bachmann MF; Maurer P J Mol Biol; 2012 Jan; 415(1):118-27. PubMed ID: 22079050 [TBL] [Abstract][Full Text] [Related]
46. Crystal structures of an enantioselective fab-fragment in free and complex forms. Parkkinen T; Nevanen TK; Koivula A; Rouvinen J J Mol Biol; 2006 Mar; 357(2):471-80. PubMed ID: 16427081 [TBL] [Abstract][Full Text] [Related]
47. Structure of an anti-DNA fab complexed with a non-DNA ligand provides insights into cross-reactivity and molecular mimicry. Schuermann JP; Henzl MT; Deutscher SL; Tanner JJ Proteins; 2004 Nov; 57(2):269-78. PubMed ID: 15340914 [TBL] [Abstract][Full Text] [Related]
48. Crystal parameters and molecular replacement of an anticholera toxin peptide complex. Shoham M; Proctor P; Hughes D; Baldwin ET Proteins; 1991; 11(3):218-22. PubMed ID: 1749774 [TBL] [Abstract][Full Text] [Related]
49. Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation. Hattori T; Lai D; Dementieva IS; Montaño SP; Kurosawa K; Zheng Y; Akin LR; Świst-Rosowska KM; Grzybowski AT; Koide A; Krajewski K; Strahl BD; Kelleher NL; Ruthenburg AJ; Koide S Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2092-7. PubMed ID: 26862167 [TBL] [Abstract][Full Text] [Related]
50. Production of a PEGylated Fab' of the anti-LINGO-1 Li33 antibody and assessment of its biochemical and functional properties in vitro and in a rat model of remyelination. Pepinsky RB; Walus L; Shao Z; Ji B; Gu S; Sun Y; Wen D; Lee X; Wang Q; Garber E; Mi S Bioconjug Chem; 2011 Feb; 22(2):200-10. PubMed ID: 21254764 [TBL] [Abstract][Full Text] [Related]
51. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes. Arevalo JH; Hassig CA; Stura EA; Sims MJ; Taussig MJ; Wilson IA J Mol Biol; 1994 Sep; 241(5):663-90. PubMed ID: 8071992 [TBL] [Abstract][Full Text] [Related]
53. Crystal Structure of a Bivalent Antibody Fab Fragment. Shahid S; Gao M; Travis Gallagher D; Pozharski E; Brinson RG; Keck ZY; Foung SKH; Fuerst TR; Mariuzza RA J Mol Biol; 2021 Jan; 433(2):166714. PubMed ID: 33220264 [TBL] [Abstract][Full Text] [Related]
54. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution. Mylvaganam SE; Paterson Y; Getzoff ED J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550 [TBL] [Abstract][Full Text] [Related]
55. PEGylation of antibody fragments for half-life extension. Jevševar S; Kusterle M; Kenig M Methods Mol Biol; 2012; 901():233-46. PubMed ID: 22723105 [TBL] [Abstract][Full Text] [Related]
56. Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. Arevalo JH; Stura EA; Taussig MJ; Wilson IA J Mol Biol; 1993 May; 231(1):103-18. PubMed ID: 8496956 [TBL] [Abstract][Full Text] [Related]
57. Crystal structure of signal regulatory protein gamma (SIRPγ) in complex with an antibody Fab fragment. Nettleship JE; Ren J; Scott DJ; Rahman N; Hatherley D; Zhao Y; Stuart DI; Barclay AN; Owens RJ BMC Struct Biol; 2013 Jul; 13():13. PubMed ID: 23826770 [TBL] [Abstract][Full Text] [Related]
58. Alternative antibody Fab' fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering. Humphreys DP; Heywood SP; Henry A; Ait-Lhadj L; Antoniw P; Palframan R; Greenslade KJ; Carrington B; Reeks DG; Bowering LC; West S; Brand HA Protein Eng Des Sel; 2007 May; 20(5):227-34. PubMed ID: 17452434 [TBL] [Abstract][Full Text] [Related]
59. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303 [TBL] [Abstract][Full Text] [Related]
60. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus. Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]